• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE VIABAHN® ENDOPROSTHESIS; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE VIABAHN® ENDOPROSTHESIS; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Catalog Number VBH130502A
Device Problems Failure to Advance (2524); Material Distortion (2977)
Patient Problem Tissue Damage (2104)
Event Date 10/12/2016
Event Type  Injury  
Manufacturer Narrative
(b)(4).Review of device manufacturing record history confirmed device met pre-release specifications.Device was discarded at user facility.Therefore, direct product analysis was not possible.Warnings section of ifu states: do not withdraw the gore® viabahn® endoprosthesis back into the introducer sheath once the endoprosthesis is fully introduced.Withdrawing the gore® viabahn® endoprosthesis back into the sheath can cause damage to the endoprosthesis, premature deployment, deployment failure, and / or catheter separation.If removal prior to deployment is necessary, withdraw the gore® viabahn® endoprosthesis to a position close to but not into the introducer sheath.Both the gore® viabahn® endoprosthesis and introducer sheath can then be removed in tandem.After removal, do not reuse the gore® viabahn® endoprosthesis or introducer sheath.
 
Event Description
Patient presented for an aaa procedure and treatment in the right internal iliac artery.As reported to gore, the patient's vessels were heavily calcified with a very tortuous anatomy.Using.035 amplatz guidewire and a 12fr sheath, the gore® viabahn® endoprosthesis was advanced up and over the bifurcation.The gore® viabahn® endoprosthesis was unable to be advanced to the intended treatment site.Decision was made to remove the gore® viabahn® endoprosthesis and attempts were made to pull the gore® viabahn® endoprosthesis back into introducer sheath.As it was pulled back, the gore® viabahn® endoprosthesis got stuck inside the sheath because the gore® viabahn® endoprosthesis became distorted and compressed.The sheath and gore® viabahn® endoprosthesis had to be removed together.When the introducer sheath was removed, the constrained gore® viabahn® endoprosthesis was left behind in the left common femoral artery.A surgical cut-down was performed to remove the damaged gore® viabahn® endoprosthesis.The patient was reported to be doing well after the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN® ENDOPROSTHESIS
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
genevieve begay
1500 n. 4th street
flagstaff, AZ 
9285263030
MDR Report Key6062205
MDR Text Key58603092
Report Number2017233-2016-00831
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial
Report Date 10/12/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/27/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/24/2017
Device Catalogue NumberVBH130502A
Device Lot Number13394138
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/25/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
.035 AMPLATZ GUIDEWIRE, 12FR SHEATH
Patient Outcome(s) Required Intervention;
Patient Age75 YR
Patient Weight75
-
-